{"transactions":[{"id":2670438,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":138307,"kind":"person","name":"Olivo Martin Sebastian","position":1,"cik":"0001855055","reported_name":"Olivo Martin Sebastian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-14T17:52:26.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":4934,"price":10.13,"value":49981.42,"ownership":{"direct":true},"balance_after":14344,"source":{"system":"sec-edgar","filing":"0001209191-21-040311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855055/000120919121040311/doc4.xml","form_type":"4"}},{"id":2670437,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":138307,"kind":"person","name":"Olivo Martin Sebastian","position":1,"cik":"0001855055","reported_name":"Olivo Martin Sebastian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-14T17:52:26.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":4959,"price":10.08,"value":49986.72,"ownership":{"direct":true},"balance_after":9410,"source":{"system":"sec-edgar","filing":"0001209191-21-040311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855055/000120919121040311/doc4.xml","form_type":"4"}},{"id":2744104,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":138307,"kind":"person","name":"Olivo Martin Sebastian","position":1,"cik":"0001855055","reported_name":"Olivo Martin Sebastian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-20T20:18:40.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares shall vest on April 19, 2022 and the remainder of the shares will vest in a series of thirty-six successive equal monthly installments measured from April 19, 2022, subject to the Reporting Person's Continuous Service (as defined in the Inducement Plan) with the Issuer through each such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":15.3,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-21-027691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855055/000120919121027691/doc4.xml","form_type":"4"}}]}